Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Freeline Therapeutics

    NASDAQ: FRLN · Real-Time Price · USD
    6.49
    0.01 (0.15%)
    At close: Feb 16, 2024, 9:37 PM

    Freeline Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 1.74M 2.39M
    Gross Profit
    		 -1.74M -2.39M
    Operating Income
    		 -98.45M -142.38M
    Interest Income
    		 904K 403.95K
    Pretax Income
    		 -88.6M -140.05M
    Net Income
    		 -88.97M -140.39M
    Selling & General & Admin
    		 30.66M 44.57M
    Research & Development
    		 66.2M 95.43M
    Other Expenses
    		 -1.57M -2.09M
    Operating Expenses
    		 95.29M 137.91M
    Interest Expense
    		 n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 95.29M 137.91M
    Income Tax Expense
    		 368K 342K
    Shares Outstanding (Basic)
    		 3.95M 2.38M
    Shares Outstanding (Diluted)
    		 3.95M 2.38M
    EPS (Basic)
    		 -22.52 -58.98
    EPS (Diluted)
    		 -22.52 -58.98
    EBITDA
    		 -97.17M -133.14M
    EBIT
    		 -98.92M -142.38M
    Depreciation & Amortization
    		 1.27M 9.24M

    Add to Watchlist